Stay updated on Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0. No trial content or user-facing information was changed.
    Difference
    0.0%
    Check dated 2026-03-23T13:38:46.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-08T23:55:07.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.4.2, replacing the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-15T14:26:52.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Page revision label updated from v3.4.0 to v3.4.1, indicating a minor update to the page version.
    Difference
    0.0%
    Check dated 2026-02-08T05:57:42.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Show glossary has been added, along with new QC metadata labels 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The previous entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.
    Difference
    0.1%
    Check dated 2026-01-25T03:23:27.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    Revision changed from v3.3.3 to v3.3.4; this is a minor version update with no changes to study content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-18T01:41:06.000Z thumbnail image

Stay in the know with updates to Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib Combo in Advanced HER2+ Breast Cancer Clinical Trial page.